AEON — Aeon Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $59.86m
- $54.70m
Annual cashflow statement for Aeon Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -55.6 | -52.6 | -36.6 |
| Depreciation | |||
| Non-Cash Items | 25.8 | 10.6 | -8.55 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 1.42 | 6.27 | -2.74 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Net Change in Other Assets & Liabilities | |||
| Cash from Operating Activities | -28.4 | -35.6 | -47.8 |
| Capital Expenditures | -0.17 | -0.306 | 0 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.17 | -0.306 | 0 |
| Financing Cash Flow Items | -1.44 | 0 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 13.6 | 40.5 | 14 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -15 | 4.62 | -33.8 |